Proline-related metabolites: Towards biological diagnosis of depression

Psychiatry and Clinical NeurosciencesVolume 77, Issue 4 p. 195-195 Editorial Proline-related metabolites: Towards biological diagnosis of depression Jordi Mayneris-Perxachs, Corresponding Author Jordi Mayneris-Perxachs [email protected] orcid.org/0000-0003-3788-3815 Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Correspondence: Jordi Mayneris-Perxachs, MD, PhD, Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital. Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI). Avinguda de França s/n, 17007, Girona, Spain. Email: [email protected]Search for more papers by this authorJosé Manuel Fernández-Real, José Manuel Fernández-Real Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Department of Medical Sciences, School of Medicine, University of Girona, Girona, SpainSearch for more papers by this author Jordi Mayneris-Perxachs, Corresponding Author Jordi Mayneris-Perxachs [email protected] orcid.org/0000-0003-3788-3815 Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Correspondence: Jordi Mayneris-Perxachs, MD, PhD, Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital. Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI). Avinguda de França s/n, 17007, Girona, Spain. Email: [email protected]Search for more papers by this authorJosé Manuel Fernández-Real, José Manuel Fernández-Real Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain Department of Medical Sciences, School of Medicine, University of Girona, Girona, SpainSearch for more papers by this author First published: 01 April 2023 https://doi.org/10.1111/pcn.13535Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021; 398: 1700– 1712. 2Bian X, Zhou N, Zhao Y et al. Identification of proline, 1-pyrroline-5-carboxylate and glutamic acid as biomarkers of depression reflecting brain metabolism using carboxylomics, a new metabolomics method. Psychiatry Clin. Neurosci. 2023; 77: 196– 204. 3Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M et al. Microbiota alterations in proline metabolism impact depression. Cell Metab. 2022; 34: 681– 701.e10. Volume77, Issue4April 2023Pages 195-195 ReferencesRelatedInformation